Haemonetics Corporation (HAE) Q4 2024 Earnings Results

Haemonetics Corp Beats on EPS, Stock Down 0.7%

Haemonetics Corp reported a slight earnings beat, but the stock fell by 0.7% in response. Investors may be concerned about the lack of revenue details and forward guidance, which could indicate uncertainty about future performance. The cautious tone from management may also have contributed to the stock's decline.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.90	N/A	+2.62%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed a cautious optimism about the company's direction. They emphasized their commitment to enhancing product offerings and operational performance.

Management highlighted ongoing efforts to improve operational efficiency.

They noted a focus on innovation to drive future growth.

Haemonetics Corp Beats on EPS, Stock Down 0.7%

Key numbers

Management commentary

Haemonetics Corporation

More earnings this week

Haemonetics Corp Beats on EPS, Stock Down 0.7%

Key numbers

Management commentary